Ensign Peak Advisors’s Hologic HOLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-62,427
Closed -$4.21M 1708
2025
Q3
$4.21M Sell
62,427
-17,035
-21% -$1.13M 0.01% 633
2025
Q2
$5.18M Sell
79,462
-42,338
-35% -$2.54M 0.01% 632
2025
Q1
$7.52M Sell
121,800
-15,466
-11% -$1.02M 0.01% 537
2024
Q4
$9.9M Buy
137,266
+13,990
+11% +$1.09M 0.02% 477
2024
Q3
$10M Buy
123,276
+17,045
+16% +$1.36M 0.02% 468
2024
Q2
$7.89M Sell
106,231
-6,506
-6% -$488K 0.01% 513
2024
Q1
$8.79M Sell
112,737
-13,263
-11% -$987K 0.02% 488
2023
Q4
$9M Buy
126,000
+3,988
+3% +$278K 0.02% 463
2023
Q3
$8.47M Sell
122,012
-2,700
-2% -$204K 0.02% 434
2023
Q2
$10.1M Sell
124,712
-42,180
-25% -$3.45M 0.02% 412
2023
Q1
$13.5M Sell
166,892
-31,496
-16% -$2.54M 0.03% 357
2022
Q4
$14.8M Sell
198,388
-116,874
-37% -$8.32M 0.03% 339
2022
Q3
$20.3M Sell
315,262
-8,890
-3% -$616K 0.05% 270
2022
Q2
$22.5M Buy
324,152
+76,960
+31% +$5.71M 0.05% 254
2022
Q1
$19M Buy
247,192
+29,365
+13% +$2.11M 0.04% 312
2021
Q4
$16.7M Buy
217,827
+166,056
+321% +$12.2M 0.03% 359
2021
Q3
$3.82M Sell
51,771
-35,151
-40% -$2.64M 0.01% 764
2021
Q2
$5.8M Buy
86,922
+50,695
+140% +$3.39M 0.01% 599
2021
Q1
$2.69M Buy
36,227
+5,640
+18% +$428K 0.01% 934
2020
Q4
$2.23M Sell
30,587
-5,849
-16% -$413K 0.01% 998
2020
Q3
$2.42M Sell
36,436
-13,671
-27% -$865K 0.01% 859
2020
Q2
$2.86M Sell
50,107
-2,470
-5% -$121K 0.01% 790
2020
Q1
$1.84M Sell
52,577
-11,400
-18% -$543K 0.01% 871
2019
Q4
$3.34M Buy
+63,977
New +$3.19M 0.01% 793

Other funds holding HOLX

Ensign Peak Advisors's HOLX Position: Q4 2025 in Review

Ensign Peak Advisors sold out of Hologic (HOLX) in Q4 2025, closing a stake of 62,427 shares — an estimated $4.21M sold.

Ensign Peak Advisors first reported a position in HOLX in Q4 2019 and held it in 24 quarters. The position peaked at $22.5M in Q2 2022. 749 funds tracked by Wall St. Rank hold HOLX as of Q4 2025.

  • Ensign Peak Advisors reported no remaining Hologic position as of Q4 2025 after selling out during the quarter.
  • Ensign Peak Advisors sold 62,427 Hologic shares in Q4 2025, an estimated $4.21M.
  • Ensign Peak Advisors first reported a position in Hologic in Q4 2019 and held it in 24 quarters.
  • Ensign Peak Advisors's Hologic position peaked at $22.5M in Q2 2022.
  • 749 funds tracked by Wall St. Rank held Hologic as of Q4 2025.

Based on Ensign Peak Advisors's 13F filing for Q4 2025, filed 12 Feb 2026.